{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:04:35Z","timestamp":1790755475260,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica, Argentina","doi-asserted-by":"crossref","award":["FONCyT-PICT-StartUp2015-0024"],"award-info":[{"award-number":["FONCyT-PICT-StartUp2015-0024"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n, Santa Fe Province, Argentina","award":["2010-35-15"],"award-info":[{"award-number":["2010-35-15"]}]},{"name":"Fundaci\u00f3n Nuevo Banco de Santa Fe, Santa Fe Province, Argentina"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cimid.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T11:56:26Z","timestamp":1556625386000},"page":"70-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications"],"prefix":"10.1016","volume":"65","author":[{"given":"Diego","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Battagliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Etcheverrigaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Kratje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cimid.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2012.03.007","article-title":"The role of vaccination in rabies prevention","volume":"2","author":"Briggs","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cimid.2019.04.009_bib0010","series-title":"WHO Expert Consultation on Rabies","author":"WHO Expert, Expert, W.H.O","year":"2013"},{"key":"10.1016\/j.cimid.2019.04.009_bib0015","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.cimid.2019.04.009_bib0020","first-page":"1","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cimid.2019.04.009_bib0025","first-page":"1","article-title":"Potential economic benefits of eliminating canine rabies","author":"Shwiff","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cimid.2019.04.009_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2017.00009","article-title":"Elimination of Dog-mediated human rabies deaths by 2030: Needs assessmnet and alternatives for progress based on dog vaccination","volume":"4","author":"Wallace","year":"2017","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.cimid.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2012.04592.x","article-title":"Developments in rabies vaccines","volume":"169","author":"Hicks","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cimid.2019.04.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.03.088","article-title":"Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate","author":"Fontana","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2019.04.009_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.02.031","article-title":"Rabies virus-like particles expressed in HEK293 cells","author":"Fontana","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2019.04.009_bib0050","first-page":"8463","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"Society"},{"key":"10.1016\/j.cimid.2019.04.009_bib0055","doi-asserted-by":"crossref","first-page":"P7","DOI":"10.1186\/1753-6561-5-S8-P7","article-title":"A strategy to obtain recombinant cell lines with high expression levels. Lentiviral vector-mediated transgenesis","volume":"5","author":"Prieto","year":"2011","journal-title":"BMC Proc."},{"key":"10.1016\/j.cimid.2019.04.009_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/616898","article-title":"Comparison of \u03b2 -Propiolactone and Formalin inactivation on Antigenicity and immune response of West Nile Virus","volume":"2015","author":"Chowdhury","year":"2015","journal-title":"Adv. Virol."},{"key":"10.1016\/j.cimid.2019.04.009_bib0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jviromet.2014.07.003","article-title":"Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicity","volume":"207","author":"Dembinski","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.cimid.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JCM.02045-09","article-title":"Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling","volume":"48","author":"Jonges","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cimid.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.20506\/rst.8.3.425","article-title":"Effect of formaldehyde and binary ethyleneimine (BEI) on the integrity of foot and mouth disease virus capsid","volume":"8","author":"Rweyemamu","year":"2016","journal-title":"Rev. Sci. Tech. l\u2019OIE"},{"key":"10.1016\/j.cimid.2019.04.009_bib0080","article-title":"Rabies-specific antibodies : measuring surrogates of protection against a fatal","volume":"4","author":"Moore","year":"2010","journal-title":"Disease"},{"key":"10.1016\/j.cimid.2019.04.009_bib0085","series-title":"WHO Expert Consultation on Rabies. Third Report","first-page":"982","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.cimid.2019.04.009_bib0090","first-page":"1","volume":"15","author":"Ram\u0131","year":"2015"},{"key":"10.1016\/j.cimid.2019.04.009_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tvjl.2007.11.009","article-title":"Veterinary vaccine development from an industrial perspective","volume":"178","author":"Heldens","year":"2008","journal-title":"Vet. J."}],"container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957119300785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957119300785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T20:09:07Z","timestamp":1562702947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147957119300785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":19,"alternative-id":["S0147957119300785"],"URL":"https:\/\/doi.org\/10.1016\/j.cimid.2019.04.009","relation":{},"ISSN":["0147-9571"],"issn-type":[{"value":"0147-9571","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications","name":"articletitle","label":"Article Title"},{"value":"Comparative Immunology, Microbiology and Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cimid.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}